NCT03364621 Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03361150 High-Intensity Interval vs. Moderate Continuous Training in Surgical Prehabilitation. Status COMPLETED Phase NA
NCT03355391 Characterization of Brazilian Colorectal Cancer Screening Population Status UNKNOWN Phase N/A
NCT03349762 Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery Status RECRUITING Phase N/A
NCT03346005 Detection of Colorectal Cancer in Patients With a Positive Fecal Immunochemical Test Using an Electronic Nose Device (AeoNoseTM) Status COMPLETED Phase NA
NCT03344614 A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT03337347 Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients Status COMPLETED Phase NA
NCT03336229 Enhancing Fitness With Preoperative Exercise in Colorectal Cancer Surgery Status UNKNOWN Phase NA
NCT03332498 Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT03329950 A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT03329183 High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28 Status UNKNOWN Phase PHASE2
NCT03326791 Aspirin in Colorectal Cancer Liver Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT03320317 Breakthrough Improvement Collaborative for ColoRectal Cancer (BIC4CRC) Status ENROLLING_BY_INVITATION Phase N/A
NCT03319459 FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03316677 Intraoperative Testing of Colorectal Anastomosis - Air or Water (Methylene Blue)? Status UNKNOWN Phase NA
NCT03312374 ctDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal Cancer Status UNKNOWN Phase N/A